Add Yahoo as a preferred source to see more of our stories on Google. On August 7, the U.S. Food and Drug Administration (FDA) approved the nalmefene hydrochloride auto-injector that is used in the ...

Naloxone Auto-Injector is specifically designed to be a medical countermeasure for military personnel or chemical incident responders against the potential threat of exposure to synthetic opioids on ...

The first nalmefene hydrochloride (HCl) auto-injector (Zurnai) brings a new tool to the fight against the opioid overdose epidemic but is not without controversy. As reported earlier this month, the ...

Please provide your email address to receive an email when new articles are posted on . Nalmefene can reduce the effects of opioid overdoses, like low BP, when administered quickly. Zurnai was ...

RICHMOND, Va.--(BUSINESS WIRE)--Please replace the release dated March 2, 2022, with the following corrected version due to multiple revisions. The updated release ...

Phillips-Medisize, in collaboration with its customer, Ascendis Pharma, was recently recognized with a third industry award for the Skytrofa Auto-Injector. The Red Dot Award recognizes the drug ...

Auto-injectors are pre-filled, single-use, self-contained drug delivery systems that allow the user to self-administer precise dosages of injectable medication quickly and easily, without the ...

Anaphylaxis is a serious, potentially life-threatening allergic reaction that can affect several organ systems in the body and may threaten breathing and blood circulation. The most common causes of ...

Lindsay Green learned that her 2-year-old son, Everett, had a peanut allergy when he was around 10 months old, leading her to learn more about how to protect her baby. Now, she has taken this concern ...

The US Food and Drug Administration (FDA) has approved the first nalmefene hydrochloride auto-injector (Zurnai; Purdue Pharma LP) for the treatment of known or suspected opioid overdose in people aged ...